Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients

NCT02044510 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
32
Enrollment
OTHER
Sponsor class

Stopped Slow recruitment and small observed effect size

Conditions

Interventions

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's